Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1

HM Chang, R Moudgil, T Scarabelli… - Journal of the American …, 2017 - jacc.org
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …

Dilated cardiomyopathy

RG Weintraub, C Semsarian, P Macdonald - The Lancet, 2017 - thelancet.com
Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and
contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal …

Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the …

MJ Ehrhardt, JM Leerink, RL Mulder… - The Lancet …, 2023 - thelancet.com
Survivors of childhood, adolescent, and young adult cancer, previously treated with
anthracycline chemotherapy (including mitoxantrone) or radiotherapy in which the heart was …

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline …

SH Armenian, MM Hudson, RL Mulder… - The Lancet …, 2015 - thelancet.com
Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …

Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management …

SE Lipshultz, MJ Adams, SD Colan, LS Constine… - Circulation, 2013 - Am Heart Assoc
1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …

Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity

EAM Feijen, WM Leisenring, KL Stratton… - JAMA …, 2019 - jamanetwork.com
Importance Anthracyclines are part of many effective pediatric cancer treatment protocols.
Most pediatric oncology treatment groups assume that the hematologic toxicity of …

Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude Lifetime Cohort …

GT Armstrong, VM Joshi, KK Ness, TH Marwick… - Journal of the American …, 2015 - jacc.org
Background: Treatment-related cardiac death is the primary, noncancer cause of mortality in
adult survivors of childhood malignancies. Early detection of cardiac dysfunction may …

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh… - Nature …, 2015 - nature.com
Anthracyclines are used in over 50% of childhood cancer treatment protocols, but their
clinical usefulness is limited by anthracycline-induced cardiotoxicity (ACT) manifesting as …

Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity

M Lotrionte, G Biondi-Zoccai, A Abbate… - The American journal of …, 2013 - Elsevier
The management of individual patients requiring anthracyclines remains challenging
because uncertainty persists on predictors of cardiotoxicity. We aimed to perform a …

Individual prediction of heart failure among childhood cancer survivors

EJ Chow, Y Chen, LC Kremer, NE Breslow… - Journal of clinical …, 2015 - ascopubs.org
Purpose To create clinically useful models that incorporate readily available demographic
and cancer treatment characteristics to predict individual risk of heart failure among 5-year …